NovelStem International (NovelStem International) Growth Rank : 0 (As of Jun. 07, 2024)

View and export this data going back to 1995. Start your Free Trial

What is NovelStem International Growth Rank?

NovelStem International has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

NovelStem International Growth Rank Related Terms

Thank you for viewing the detailed overview of NovelStem International's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

NovelStem International (NovelStem International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » NovelStem International Corp (OTCPK:NSTM) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

2255 Glades Road, Suite 221A, Boca Raton, FL, USA, 33431

Website

https://www.novelstem.com

NovelStem International Corp owns novel stem-cell-based diagnostic technology for predicting patients' resistance to cancer therapies. The technology is also being used for genetic research related to other medical therapies.

Executives

Baker Street Capital Management, Llc	10 percent owner	1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067
Vadim Perelman	10 percent owner	1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067
Baker Street Capital L.p.	10 percent owner	1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067
Stephen Gans	director, 10 percent owner	14850 NW 44TH COURT, OPA LOCKA FL 33054
Shannon River Partners Lp	10 percent owner	850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022
Shannon River Fund Management Co Llc	10 percent owner	850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022
Shannon River Partners Ii, Lp	10 percent owner	850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022
Doonbeg Fund Lp	10 percent owner	850 THIRD AVE, 13TH FLOOR, New York ny 10022
Spencer M. Waxman	director	C/O SHANNON RIVER PARTNERS, 800 THIRD AVENUE 30TH FLOOR, NEW YORK NY 10022
Stanley Morgan	10 percent owner	1585 BROADWAY, NEW YORK NY 10036
Robert D. Epstein	director	2255 GLADES ROAD, BOCA RATON FL 33431
Coghill Capital Management Llc	10 percent owner	233 SOUTH WACKER DRIVE, SUITE 8439, CHICAGO IL 60606
Ccm Master Fund Ltd	10 percent owner	C/O MORGAN STANLEY FUND SERVICES (CAYMAN, LTD CENTURY YARD CRICKET SQ HUTCHINGS DR, PO BOX 2681 GEORGE TOWN E9 00000
Clint D Coghill	10 percent owner
Scott Gomez	officer: Chief Accounting Officer

NovelStem International (NovelStem International) Headlines

From GuruFocus

NewStem Announces $4 million Seed Investment

By PRNewswire PRNewswire • 07-16-2018

Hollywood Media Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 05-17-2010

Hollywood Media Corp. Reports Operating Results (10-K/A)

By gurufocus 10qk • 04-30-2010

Hollywood Media Corp. Reports Operating Results (10-Q)

By gurufocus • 05-11-2009